Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy

IMPORTANCE: The number of older adults with head and neck squamous cell carcinoma (HNSCC) is increasing, and these patients are underrepresented in clinical trials. It is unclear whether the addition of chemotherapy or cetuximab to radiotherapy is associated with improved survival in older adults wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Marschner, Sebastian, Haderlein, Marlen, Fabian, Alexander, Weymann, Maria, Behrens, Max, Senger, Carolin, Dickstein, Daniel R., Kraft, Johannes, von der Grün, Jens, Chen, Eric, Aquino-Michaels, Todd, Domschikowski, Justus, Bickel, Amanda, Altay-Langguth, Alev, Kalinauskaite, Goda, Lewitzki, Victor, Ferentinos, Konstantinos, Zamboglou, Constantinos, Schnellhardt, Sören, Haehl, Erik, Spohn, Simon K.B., Gkika, Eleni, Zöller, Daniela, Guckenberger, Matthias, Budach, Volker, Belka, Claus, Bakst, Richard, Mayer, Arnulf, Schmidberger, Heinz, Grosu, Anca-Ligia, Balermpas, Panagiotis, Stromberger, Carmen, Nicolay, Nils H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941890/
https://www.ncbi.nlm.nih.gov/pubmed/36808242
http://dx.doi.org/10.1001/jamanetworkopen.2023.0090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941890/
https://www.ncbi.nlm.nih.gov/pubmed/36808242
http://dx.doi.org/10.1001/jamanetworkopen.2023.0090

Ejemplares similares